Aug 25 2010
Prollenium and Canderm GP, an affiliate of sanofi-aventis Canada, have entered into a supply and distribution partnership for Ovita HV, a Hyaluronic Acid (HA) based dermal filler.
Ovita is based on the highly successful Revanesse Family of Products approved for use in Canada and available in over 70 countries spanning North America, Europe, Asia-Pacific, South America and the Middle East.
"Prollenium is excited to be the partner of choice for Canderm GP in this endeavor. We have been working hard to expand our business globally and this relationship with a long-standing and reputable company like Canderm is a strong and positive step towards expanding our sales and increasing the number of physicians who are using our complete line of products. Working with one of the largest dermatology focused companies in Canada further enhances our network," says Ario Khoshbin, President of Prollenium Medical Technologies.
Source: PROLLENIUM MEDICAL TECHNOLOGIES INC.